AP2015008534A0 - Diclofenac composition - Google Patents

Diclofenac composition

Info

Publication number
AP2015008534A0
AP2015008534A0 AP2015008534A AP2015008534A AP2015008534A0 AP 2015008534 A0 AP2015008534 A0 AP 2015008534A0 AP 2015008534 A AP2015008534 A AP 2015008534A AP 2015008534 A AP2015008534 A AP 2015008534A AP 2015008534 A0 AP2015008534 A0 AP 2015008534A0
Authority
AP
ARIPO
Prior art keywords
diclofenac composition
diclofenac
composition
Prior art date
Application number
AP2015008534A
Other languages
English (en)
Inventor
Madhavlal Govindlal Patel
Shashikant Prabhudas Kurani
Sachin Dinesh Patel
Original Assignee
Themis Medicare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54198802&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2015008534(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Themis Medicare Ltd filed Critical Themis Medicare Ltd
Publication of AP2015008534A0 publication Critical patent/AP2015008534A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2015008534A 2012-12-28 2013-12-27 Diclofenac composition AP2015008534A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3704MU2012 2012-12-28
PCT/IN2013/000805 WO2014102824A1 (fr) 2012-12-28 2013-12-27 Composition de diclofénac

Publications (1)

Publication Number Publication Date
AP2015008534A0 true AP2015008534A0 (en) 2015-06-30

Family

ID=54198802

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2015008534A AP2015008534A0 (en) 2012-12-28 2013-12-27 Diclofenac composition

Country Status (25)

Country Link
US (1) US20140187635A1 (fr)
EP (1) EP2938325B8 (fr)
JP (1) JP6117939B2 (fr)
KR (1) KR101730284B1 (fr)
CN (1) CN104968331A (fr)
AP (1) AP2015008534A0 (fr)
AU (1) AU2013368849B2 (fr)
BR (1) BR112015015699B1 (fr)
CL (1) CL2015001869A1 (fr)
EA (1) EA035079B1 (fr)
ES (1) ES2721400T3 (fr)
HK (1) HK1211858A1 (fr)
HU (1) HUE045030T2 (fr)
IL (1) IL239395A0 (fr)
MA (1) MA38292A1 (fr)
MX (1) MX365375B (fr)
MY (1) MY184886A (fr)
PE (1) PE20151208A1 (fr)
PH (1) PH12015501479B1 (fr)
SG (1) SG11201504577UA (fr)
SI (1) SI2938325T1 (fr)
TR (1) TR201905806T4 (fr)
UA (1) UA114123C2 (fr)
WO (1) WO2014102824A1 (fr)
ZA (1) ZA201504258B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524473B1 (ko) * 2014-12-22 2015-06-02 주식회사 한국팜비오 주사제 조성물
WO2016170401A1 (fr) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Nouvelle composition injectable de diclofénac sodique
US11110073B2 (en) 2017-03-24 2021-09-07 Cadila Healthcare Limited Storage stable aqueous injectable solution comprising diclofenac
BR112020002804A2 (pt) 2017-08-24 2020-07-28 Novo Nordisk A/S composição farmacêutica líquida, e, kit
GB201720992D0 (en) * 2017-12-15 2018-01-31 Hooper Mark A medical use
GR1009729B (el) * 2018-08-02 2020-05-15 Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια Σταθερος ενεσιμος συνδυασμος
SG11202103374TA (en) * 2018-11-16 2021-05-28 Seikagaku Kogyo Co Ltd Pharmaceutical composition
US20220280463A1 (en) 2019-09-09 2022-09-08 Ftf Pharma Private Limited Pharmaceutical formulations comprising diclofenac
US11707443B2 (en) 2019-09-26 2023-07-25 Rk Pharma Inc. Storage stable aqueous parenteral solutions comprising diclofenac
US12246024B2 (en) * 2019-12-13 2025-03-11 Free State Pharma Inc Compositions and methods for controlling cerumen production
IL294521A (en) * 2020-02-18 2022-09-01 Novo Nordisk As glp-1 compounds and their uses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324193A1 (de) 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
DE3446873A1 (de) 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
AU662160B2 (en) * 1991-07-04 1995-08-24 Taisho Pharmaceutical Co., Ltd. Analgesic
US5389681A (en) 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
ZA949182B (en) 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Kdl株式会社 ピリドン誘導体の溶液状医薬組成物
US20050203000A1 (en) * 2003-03-26 2005-09-15 Sutter Diane E. Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection
WO2005027977A2 (fr) * 2003-09-22 2005-03-31 Agis Industries (1983) Ltd. Compositions de diclofenac destinees au traitement d'affections cutanees
DE602004025151D1 (de) 2004-03-10 2010-03-04 Shimoda Biotech Pty Ltd Stabile injizierbare Diclofenac- Zubereitungen
US20050214230A1 (en) * 2004-03-23 2005-09-29 J. B. Chemicals & Pharmaceuticals Ltd. Novel stomatological gel
EA013616B1 (ru) * 2005-02-01 2010-06-30 Троикаа Фармасьютикалз Лтд. Инъекционные препараты диклофенака и его фармацевтически приемлемых солей
BRPI0611170A2 (pt) * 2005-05-27 2010-08-17 Panacea Biotec Ltd composições injetáveis e processo para o preparo de tais composições
BRPI0921654A2 (pt) 2008-11-28 2016-02-10 Advance Holdings Ltd formulação farmacêutica

Also Published As

Publication number Publication date
US20140187635A1 (en) 2014-07-03
MA38292A1 (fr) 2017-06-30
WO2014102824A8 (fr) 2014-10-02
BR112015015699A2 (pt) 2017-07-11
WO2014102824A1 (fr) 2014-07-03
HUE045030T2 (hu) 2019-12-30
ES2721400T8 (es) 2019-10-10
MY184886A (en) 2021-04-29
PH12015501479B1 (en) 2019-11-15
BR112015015699B1 (pt) 2022-09-27
EA035079B1 (ru) 2020-04-24
PE20151208A1 (es) 2015-08-23
KR101730284B1 (ko) 2017-04-25
JP2016508139A (ja) 2016-03-17
AU2013368849A1 (en) 2015-07-09
TR201905806T4 (tr) 2019-05-21
SG11201504577UA (en) 2015-07-30
AU2013368849B2 (en) 2017-01-12
MX2015008369A (es) 2016-03-01
PH12015501479A1 (en) 2015-09-21
SI2938325T1 (sl) 2019-06-28
KR20150090250A (ko) 2015-08-05
ZA201504258B (en) 2016-04-28
MX365375B (es) 2019-05-31
JP6117939B2 (ja) 2017-04-19
HK1211858A1 (en) 2016-06-03
EP2938325B8 (fr) 2019-09-25
CN104968331A (zh) 2015-10-07
EP2938325B1 (fr) 2019-04-10
ES2721400T3 (es) 2019-07-31
UA114123C2 (xx) 2017-04-25
EP2938325A1 (fr) 2015-11-04
CL2015001869A1 (es) 2015-10-23
EA201591230A1 (ru) 2015-11-30
IL239395A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
IL236304A0 (en) Formulations for diclofenac
GB2506426B (en) Composition
PL2804487T3 (pl) Kompozycja
IL239395A0 (en) Diclofenac preparation
ZA201500519B (en) Composition
GB2498803B (en) Composition
EP2878295A4 (fr) Composition
GB201218954D0 (en) Composition
GB2508825B (en) Composition
GB201206035D0 (en) Composition
HRP20190326T1 (hr) Pripravak
ZA201407419B (en) Composition
IL236357A0 (en) The composition of misoprostol
EP2910537A4 (fr) Composition d'agent générant du gaz
GB201218195D0 (en) Composition
GB201209597D0 (en) Composition
GB201208133D0 (en) Composition
GB201311517D0 (en) Composition
GB201219383D0 (en) Composition
EP2711011A4 (fr) Composition contenant du panaxadiol
SG11201405751TA (en) Composition
GB201223526D0 (en) Composition
GB201223224D0 (en) Composition
GB201221334D0 (en) Composition
GB201220838D0 (en) Composition